CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML 125 MG / 5 ML
CEFPROZIL : 125 MG / 5 ML · DIN 02163675 · BRISTOL-MYERS SQUIBB CANADA
Health Canada status: CANCELLED POST MARKET
What is CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML?
CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML 125 MG / 5 ML contains CEFPROZIL : 125 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02163675, held by BRISTOL-MYERS SQUIBB CANADA, supplied as POWDER FOR SUSPENSION for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 22-Jan-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML used for?
CEFZIL (cefprozil) is indicated for the treatment of upper respiratory tract infections (Pharyngitis/tonsillitis, Otitis media, Acute sinusitis), uncomplicated skin and skin-structure infections, and uncomplicated urinary tract infections caused by susceptible strains of designated microorganisms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML called?
The same molecule, CEFPROZIL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| CEFPROZ | Latin | Bahrain |
| CEFZIL | Latin | Czechia |
| CEFZIL O.S. | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02163675 |
|---|---|
| Brand name | CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML |
| Generic / active ingredient | CEFPROZIL : 125 MG / 5 ML |
| Manufacturer | BRISTOL-MYERS SQUIBB CANADA |
| Strength | 125 MG / 5 ML |
| Dosage form | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01DC10 CEFPROZIL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-Jan-2018 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02163675 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2163675 |
| Brand name | CEFZIL POWDER FOR ORAL SUSPENSION-125MG/5ML |
| Active ingredient / INN | CEFPROZIL : 125 MG / 5 ML |
| ATC code | J01DC10 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | BRISTOL-MYERS SQUIBB CANADA |
How is it stored and handled?
CEFZIL tablets and powder for oral suspension should be stored at room temperature (15 - 30 °C) and protected from light and excessive humidity. The reconstituted CEFZIL oral suspension must be stored in the refrigerator (2 °C - 8 °C) for up to 14 days. Keep container tightly closed. Discard unused portion after 14 days.
How is it supplied?
CEFZIL 250 mg and 500 mg tablets are available in bottles of 100. CEFZIL powder for oral suspension is available in bottles of 75 and 100 mL.
Which pack is which?
| Strength on the label | 125 MG / 5 ML |
|---|---|
| Dosage form | POWDER FOR SUSPENSION |
| Route | ORAL |
| Packaging as described in the monograph | CEFZIL 250 mg and 500 mg tablets are available in bottles of 100. CEFZIL powder for oral suspension is available in bottles of 75 and 100 mL. |
| Storage | CEFZIL tablets and powder for oral suspension should be stored at room temperature (15 - 30 °C) and protected from light and excessive humidity. The reconstituted CEFZIL oral suspension must be stored in the refrigerator (2 °C - 8 °C) for up to 14 days. Keep container tightly closed. Discard unused portion after 14 days. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
What can be used instead?
Other Canadian products sharing ATC code J01DC10 CEFPROZIL. 7 of 34 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-CEFPROZIL | 125 MG / 5 ML | POWDER FOR SUSPENSION | AURO PHARMA INC | MARKETED | DIN 02347261 |
| AURO-CEFPROZIL | 250 MG / 5 ML | POWDER FOR SUSPENSION | AURO PHARMA INC | MARKETED | DIN 02347288 |
| AURO-CEFPROZIL | 500 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02347253 |
| SPC-CEFPROZIL | 250 MG | TABLET | SUN PHARMA CANADA INC | MARKETED | DIN 02293528 |
| SPC-CEFPROZIL | 500 MG | TABLET | SUN PHARMA CANADA INC | MARKETED | DIN 02293536 |
| TARO-CEFPROZIL | 125 MG / 5 ML | POWDER FOR SUSPENSION | SUN PHARMA CANADA INC | MARKETED | DIN 02329204 |
| TARO-CEFPROZIL | 250 MG / 5 ML | POWDER FOR SUSPENSION | SUN PHARMA CANADA INC | MARKETED | DIN 02293579 |
| APO-CEFPROZIL | 125 MG / 5 ML | POWDER FOR SUSPENSION | APOTEX INC | DORMANT | DIN 02293943 |
| APO-CEFPROZIL | 250 MG | TABLET | APOTEX INC | DORMANT | DIN 02292998 |
| APO-CEFPROZIL | 250 MG / 5 ML | POWDER FOR SUSPENSION | APOTEX INC | DORMANT | DIN 02293951 |
Who else supplies CEFPROZIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CEFPROZIL appears in 45 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does CEFPROZIL cost around the world?
CEFPROZIL is listed on 9 national price registers Nexara tracks, across 66 pack listings published on 8 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 4 | 25 | 03 Sep 2026 |
| Greece | producer price (ex-factory) | 13 | 13 | 03 Sep 2026 |
| Saudi Arabia | public | 7 | 7 | 01 Sep 2026 |
| South Africa | single exit price | 6 | 7 | 01 Sep 2026 |
| Bahrain | retail (max) | 1 | 3 | 01 Sep 2026 |
| Czechia | max producer price (ex-factory) | 2 | 3 | 03 Sep 2026 |
| Hungary | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| Slovakia | categorised final price | 3 | 3 | 02 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 2 | 2 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.